Empress Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Empress Therapeutics is a biotechnology research company focused on creating oral medicines by leveraging chemistry generated within the human body. The company employs a platform-driven approach that links genetic information with body-produced drug-like chemistry to accelerate discovery and reduce development costs for a wide range of diseases. Its aim is to deliver therapies more quickly and with greater predictability than traditional approaches.

Based in Watertown, Massachusetts, the company was founded in 2020 by Flagship Pioneering and operates as a small to midsize biotech organization. In August 2023, Empress Therapeutics announced the appointment of Dawn Thompson as Senior Vice President, Head of Platform Development. The company targets drug discovery programs and pharmaceutical developers seeking faster, more predictable development of oral therapies for diverse diseases.

Sign up for free to view info

Company overview Employee directory